Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,488 public trials 2,849 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Quantra Point-of-Care Hemostasis Monitoring

NCT06328647

Conditions: Bleeding, Cardiovascular Diseases, Hematologic Diseases, +8 more
Locations: Cleveland Clinic Foundation Cleveland, Ohio, United States

View Trial Details

Active, not recruiting

Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia

NCT04657094

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +21 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe Hemophilia A

NCT07548411

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China

View Trial Details

Active, not recruiting

Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)

NCT04439123

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

NCT04126200

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: GSK Investigational Site Atlanta, Georgia, United States

GSK Investigational Site Indianapolis, Indiana, United States

GSK Investigational Site Boston, Massachusetts, United States

GSK Investigational Site Grand Rapids, Michigan, United States

View all 38 locations

View Trial Details

Active, not recruiting

Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia

NCT04872790

Conditions: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Burkitt Lymphoma, +23 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Active, not recruiting

A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

NCT03560882

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Cancer, +13 more
Locations: University of Kansas Cancer Center - CRC Fairway, Kansas, United States

View Trial Details

Active, not recruiting

Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)

NCT04439175

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

NCT04401748

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Duplicate_Providence Medical Foundation /ID# 222633 Fullerton, California, United States

University of California, Los Angeles /ID# 221760 Los Angeles, California, United States

Torrance Memorial Physician Network Cancer Care /ID# 222702 Torrance, California, United States

PIH Health Whittier Hospital /ID# 222647 Whittier, California, United States

View all 220 locations

View Trial Details

Active, not recruiting

A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant

NCT04872595

Conditions: Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +15 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions